180 Life Sciences Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by 180 Life Sciences Corp. (trading symbol: ATNF) on April 13, 2022. The registrant is a Delaware corporation and an emerging growth company. The report addresses corporate governance events related to the upcoming 2022 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the Board of Directors' determination to hold the 2022 Annual Meeting of Stockholders on June 14, 2022. The specific time and location will be disclosed in the definitive proxy statement.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: June 14, 2022.
- Stockholder Proposals: Proposals intended for inclusion in proxy materials under Rule 14a-8 must be received by the Corporate Secretary by the close of business on April 25, 2022.
- Director Nominations: Stockholder nominations for directors or other business proposals must also be received by April 25, 2022, to be considered timely.
- Submission Address: 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306, Attention: Corporate Secretary.
Key Facts for Investor Verification
- Verify the definitive proxy statement for the exact time and location of the June 14, 2022, Annual Meeting.
- Confirm the April 25, 2022, deadline for submitting stockholder proposals and director nominations.
- Note that proposals submitted after the April 25 deadline will be considered untimely.
- Review the Company's Amended and Restated Bylaws for additional requirements regarding stockholder proposals.